Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

620
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Country-specific differences in the association between obesity risk factors in two high-income countries: a cross-sectional analysis from the Prospective Urban Rural Epidemiology (PURE) study.

BMC public health·2026
Same author

Life-course trajectories and modifiable risk factors for incident walking limitation and mortality in 25 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

The lancet. Healthy longevity·2026
Same author

Pre-pregnancy weight in Swedish women and the risk of gestational diabetes and subsequent type 2 diabetes-a population-based cohort study.

EClinicalMedicine·2026
Same author

Heart Failure Among 173,000 Community-Dwelling Participants From 25 Low-, Middle-, and High-Income Countries in the PURE Study.

Journal of the American College of Cardiology·2026
Same author

The demands-control-support work stress model and risk of ischemic heart disease: causal inference based on observational epidemiology.

Scandinavian journal of work, environment & health·2026
Same author

Pharmacological treatment after a first myocardial infarction in Sweden - long-term adherence and prognosis.

European heart journal. Quality of care & clinical outcomes·2026
Same journal

Risk factor target achievement in relation to incident cardiovascular disease among individuals with cardiovascular-kidney-metabolic syndrome stage 1-3: results from a nationwide cohort study.

BMC cardiovascular disorders·2026
Same journal

Association of routine inflammatory biomarkers and derived indices with heart failure progression in preserved ejection fraction.

BMC cardiovascular disorders·2026
Same journal

Measuring left ventricular global longitudinal strain in different contrast-enhanced echocardiography modes: a feasibility study.

BMC cardiovascular disorders·2026
Same journal

Veno-arterial ECMO in fulminant myocarditis: a retrospective single-center case series.

BMC cardiovascular disorders·2026
Same journal

The prognostic value of the prognostic nutritional index for short- and long-term outcomes in coronary care unit patients.

BMC cardiovascular disorders·2026
Same journal

Prognostic value of the TAPSE/PASP-ratio in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair.

BMC cardiovascular disorders·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.6K

Continuing decrease in coronary heart disease mortality in Sweden.

Johanna Berg1, Lena Björck, Georgios Lappas

  • 1Department of Medicine, Sahlgrenska University Hospital, Östra, c/o Annika Rosengren, CK Plan 2, SE-416 85 Gothenburg, Sweden. johanna.berg@gu.se.

BMC Cardiovascular Disorders
|January 23, 2014
PubMed
Summary
This summary is machine-generated.

Coronary heart disease (CHD) deaths continue to fall in Sweden across all age groups. While younger men showed a slight slowdown in decline, a flattening of CHD mortality was not confirmed in Swedish young adults.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.0K

Related Experiment Videos

Last Updated: May 3, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.6K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.0K

Area of Science:

  • Cardiovascular epidemiology
  • Public health surveillance
  • Mortality trends

Background:

  • Coronary heart disease (CHD) mortality has declined in Western countries.
  • Recent reports suggest a potential flattening of this decline in younger populations.
  • This study investigates CHD mortality trends in Swedish young adults.

Purpose of the Study:

  • To determine if coronary heart disease (CHD) mortality decline is flattening among Swedish young adults.
  • To analyze CHD mortality trends across different age groups in Sweden.
  • To assess the overall impact of interventions on CHD mortality rates.

Main Methods:

  • Analysis of CHD mortality data in Sweden from 1987 to 2009.
  • Inclusion of individuals aged 35 to 84 years.
  • Utilized Joinpoint software to examine annual percent changes in mortality rates.

Main Results:

  • Overall CHD mortality decreased significantly: 67.4% in men and 65.1% in women.
  • Younger men (35-54 years) exhibited a modest early attenuation in the rate of decline.
  • No confirmed flattening of CHD mortality decline was observed in young adults; rates continued to fall in all groups.

Conclusions:

  • Coronary heart disease (CHD) deaths are still decreasing in Sweden.
  • The study did not confirm a flattening of CHD mortality decline in young people.
  • Continued monitoring of CHD mortality trends, especially in young adults, is essential.